He, Xu
Yao, Wei
Zhu, Ji-Ding
Jin, Xin
Liu, Xin-Yuan
Zhang, Kang-Jian
Zhao, Shou-Liang
Funding for this research was provided by:
National Nature Science Foundation of China (82071109)
Yuansong Academician Expert Workstation Grants (19R1002275468, 20R9004076411, 21R4007547098)
Article History
Received: 16 July 2023
Accepted: 19 September 2023
First Online: 3 October 2023
Declarations
:
: The animal experiments in this study was approved by the institutional Ethics Committee (IACUC), Shanghai LideBiotech Co., Ltd (LDIACUC 006).
: Written informed consent for publication was obtained from all participants.
: Kang-Jian Zhang holds an ownership interest (including patents of YSCH-01) in Yuansong Biotechnology Limited Company, while Xin-Yuan Liu is a board member of Yuansong Biotechnology Co., Ltd. No potential conflicts of interest were disclosed by the other authors.